MIRM vs MKC · rev $336.1M vs P/E 8.4, rev $3.81B
Mirum Pharmaceuticals Inc (MIRM) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
MIRM currently screens at market cap $6.22B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the MIRM and MKC stock pages for the full models.
Not investment advice.